Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XBI vs BIPIX overlap: 28% of top holdings shared

Bottom line

How much do XBI and BIPIX overlap?

28% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 15.2% of XBI's assets and 12.8% of BIPIX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

XBIBIPIX
Weight overlap (top 25)28%
Shared holdings12
Weight in shared holdings15.2%12.8%
Total positions161159
Expense ratio0.35%1.52%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings XBI and BIPIX have in common

Holding% of XBI% of BIPIXOverlap
Apogee Therapeutics Inc1.49%1.29%1.29%
Twist Bioscience Corp1.41%1.08%1.08%
Oruka Therapeutics Inc1.38%1.20%1.20%
Kymera Therapeutics Inc1.36%1.05%1.05%
Praxis Precision Medicines Inc1.29%1.02%1.02%
Erasca Inc1.27%1.08%1.08%
Revolution Medicines Inc1.20%1.04%1.04%
CG oncology Inc1.20%1.03%1.03%
Dianthus Therapeutics Inc1.18%1.12%1.12%
Natera Inc1.16%0.99%0.99%
Cogent Biosciences Inc1.14%0.99%0.99%
Travere Therapeutics Inc1.13%0.95%0.95%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XBI

  1. State Street Global Advisors — 5.87%
  2. Moderna Inc — 1.41%
  3. Viking Therapeutics Inc — 1.30%
  4. Rhythm Pharmaceuticals Inc — 1.20%
  5. SELLAS Life Sciences Group Inc — 1.19%
  6. Vaxcyte Inc — 1.19%
  7. Cytokinetics Inc — 1.18%
  8. Scholar Rock Holding Corp — 1.16%
  9. Roivant Sciences Ltd — 1.16%
  10. Mirum Pharmaceuticals Inc — 1.16%
  11. Ultragenyx Pharmaceutical Inc — 1.14%
  12. Alkermes PLC — 1.11%
  13. Krystal Biotech Inc — 1.10%

Only in BIPIX

  1. N/a — 6.70%
  2. N/a — 5.15%
  3. N/a — 4.12%
  4. N/a — 4.12%
  5. N/a — 3.16%
  6. Agpxx — 2.40%
  7. N/a — 1.24%
  8. Spyre Therapeutics Inc — 1.04%
  9. Protagonist Therapeutics Inc — 1.03%
  10. Regeneron Pharmaceuticals Inc — 1.01%
  11. Arrowhead Pharmaceuticals Inc — 0.95%
  12. Roivant Sciences Ltd — 0.95%
  13. Relay Therapeutics Inc — 0.95%

Asset mix

Asset typeXBIBIPIX
Stocks99.9%78.4%
Repurchase agreements—24.5%
Cash & short-term funds5.9%2.4%
Equity derivatives0.1%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryXBIBIPIX
US100.8%98.3%
IE1.2%1.0%
BM1.2%1.0%
NL1.0%0.8%
CH1.0%0.8%
VG0.5%0.4%
KY—0.2%
CA0.2%0.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do XBI and BIPIX overlap?
About 28% by weight. 12 securities appear in both funds' top 25 holdings; they make up 15.2% of XBI's assets and 12.8% of BIPIX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do XBI and BIPIX have in common?
The largest shared holdings are Apogee Therapeutics Inc, Oruka Therapeutics Inc, Dianthus Therapeutics Inc, Erasca Inc, Twist Bioscience Corp.
Should I own both XBI and BIPIX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, XBI or BIPIX?
XBI is broader, with 161 positions versus 159 for BIPIX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.